|
ATR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62558855265615E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.79853917817263E-12 |
| Normal-vs-Stage2 |
8.95770000397533E-08 |
| Normal-vs-Stage3 |
1.09234843392869E-12 |
| Normal-vs-Stage4 |
3.80029341329191E-12 |
| Stage1-vs-Stage2 |
7.374600E-01 |
| Stage1-vs-Stage3 |
4.421700E-02 |
| Stage1-vs-Stage4 |
9.377700E-03 |
| Stage2-vs-Stage3 |
2.952200E-01 |
| Stage2-vs-Stage4 |
6.524000E-02 |
| Stage3-vs-Stage4 |
3.438200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0547118733939E-14 |
| Normal-vs-AfricanAmerican |
6.48850000000145E-05 |
| Normal-vs-Asian |
8.22300000313803E-08 |
| Caucasian-vs-AfricanAmerican |
5.400600E-01 |
| Caucasian-vs-Asian |
5.469000E-01 |
| AfricanAmerican-vs-Asian |
8.774800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48658862997308E-13 |
| Normal-vs-Female |
1.68809410894255E-12 |
| Male-vs-Female |
2.848400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.01619831941002E-11 |
| Normal-vs-Age(41-60Yrs) |
7.10653758062563E-13 |
| Normal-vs-Age(61-80Yrs) |
1.22120091816669E-11 |
| Normal-vs-Age(81-100Yrs) |
5.968100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.371360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.860220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.838800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.962600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.455200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.263400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.541700E-03 |
| Classical-VS-Follicular |
7.882400E-01 |
| Classical-VS-Other |
3.763400E-01 |
| Classical-VS-Normal |
2.2077000227938E-09 |
| Tall-VS-Follicular |
1.374310E-02 |
| Tall-VS-Other |
6.384600E-01 |
| Tall-VS-Normal |
7.94880050669633E-10 |
| Follicular-VS-Other |
4.304800E-01 |
| Follicular-VS-Normal |
1.61160000011762E-07 |
| Other-VS-Normal |
1.216420E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13051798425568E-13 |
| Normal-vs-N1 |
2.90629997845571E-09 |
| N0-vs-N1 |
6.583000E-01 |
|
|
